RKDA · Arcadia Biosciences, Inc. · Suppliers & Customers
$0.17
-0.02 (-9.90%)
At close · Nov 19
Return incl. dividend (before tax)
Q1 2025 earnings call transcript
Going-concern doubt
— flagged Nov 12, 2026
Substantial doubt about the company's ability to continue as a going concern.
“We believe that our existing cash and cash equivalents will not be sufficient to meet our anticipated cash requirements for at least the next 12 months from the issuance date of these condensed consolidated financial statements, which raises substantial doubt about the Company’s ability to continue as a going concern, and the audit opinion on our 2025 audited consolidated financial statements includes a going concern explanatory paragraph regarding substantial doubt about the Company’s ability to continue as a going concern.”View the 10-Q filed Nov 12, 2026
Market Cap
$1.03M
Shares
6.07M
Volume · Nov 19
499.11K
Avg daily vol (3M)
2.27M
You came from your AI assistant. Add Equibles to it and ask about this data directly, free.
Supply Chain
Customers, suppliers, competitors and partners, private companies included: the ones RKDA names, and the companies that name RKDA.
Read supply chains in your AI or your code through MCP and the API →
Pro
See who RKDA sells to, buys from and competes with
- 0 suppliers
- 0 customers
- 4 competitors
Pro names each company, links it to its own page, shows any revenue share the filing states, and quotes the sentence it comes from.
Key facts
CIK
1469443
CUSIP
039014303
13F (30d)
18 filings
17 filers
Visit website
Investor relations